206 related articles for article (PubMed ID: 30016492)
1. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis.
Gezgin Yıldırım D; Baglan E; Güngörer V; Yıldız C; Tuncez S; Bülbül M; Acar B; Bakkaloğlu SA
Int J Rheum Dis; 2023 Aug; 26(8):1504-1511. PubMed ID: 37288472
[TBL] [Abstract][Full Text] [Related]
3. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
4. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
6. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
Walling HW; Gerami P; Sontheimer RD
Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and management of clinically amyopathic juvenile dermatomyositis across four academic centers.
Bradley F; Bayer ML; Co DO; Chiu Y; Huber AM; Ahmad RC; Baris HE; Oberle EJ; Kim S
Pediatr Dermatol; 2021 Mar; 38(2):413-419. PubMed ID: 33438772
[TBL] [Abstract][Full Text] [Related]
8. Medications received by patients with juvenile dermatomyositis.
Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
[TBL] [Abstract][Full Text] [Related]
9. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
10. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.
Tansley SL; Betteridge ZE; Gunawardena H; Jacques TS; Owens CM; Pilkington C; Arnold K; Yasin S; Moraitis E; Wedderburn LR; McHugh NJ;
Arthritis Res Ther; 2014 Jul; 16(4):R138. PubMed ID: 24989778
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
[TBL] [Abstract][Full Text] [Related]
12. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
13. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
[TBL] [Abstract][Full Text] [Related]
14. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
[TBL] [Abstract][Full Text] [Related]
15. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.
Hussain A; Rawat A; Jindal AK; Gupta A; Singh S
Rheumatol Int; 2017 May; 37(5):807-812. PubMed ID: 28331982
[TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
[TBL] [Abstract][Full Text] [Related]
18. Periorbital rash and scaly plaques in a 13-year-old boy.
Silvestre-Torner N; Díaz Delgado-Peñas R; Collado-Ramos P; Román-Sainz J; Gruber-Velasco F; Imbernón-Moya A; Dorado-Fernández M; Nogales-Moro A
JAAD Case Rep; 2022 May; 23():147-150. PubMed ID: 35509500
[No Abstract] [Full Text] [Related]
19. Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Deakin CT; Yasin SA; Simou S; Arnold KA; Tansley SL; Betteridge ZE; McHugh NJ; Varsani H; Holton JL; Jacques TS; Pilkington CA; Nistala K; Wedderburn LR;
Arthritis Rheumatol; 2016 Nov; 68(11):2806-2816. PubMed ID: 27214289
[TBL] [Abstract][Full Text] [Related]
20. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
